全反式维甲酸与砷联合治疗对新诊断的低至中危急性早幼粒细胞白血病患者有益：基于多变量分析的长期随访 - Suppr | 超能文献

相似文献

1

All-trans retinoic acid and arsenic combination therapy benefits low-to-intermediate-risk patients with newly diagnosed acute promyelocytic leukaemia: a long-term follow-up based on multivariate analysis.全反式维甲酸与砷联合治疗对新诊断的低至中危急性早幼粒细胞白血病患者有益：基于多变量分析的长期随访

Br J Haematol. 2015 Oct;171(2):277-280. doi: 10.1111/bjh.13375. Epub 2015 Mar 30.

2

Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.新诊断的急性早幼粒细胞白血病患者经低剂量全反式维甲酸联合小剂量化疗诱导缓解后，加用静脉注射三氧化二砷巩固治疗的长期疗效。

Hematol Oncol. 2014 Mar;32(1):40-6. doi: 10.1002/hon.2076. Epub 2013 Aug 20.

3

Long-term survival of acute promyelocytic leukaemia patients treated with arsenic and retinoic acid.接受砷剂和维甲酸治疗的急性早幼粒细胞白血病患者的长期生存情况。

Br J Haematol. 2016 Sep;174(5):820-2. doi: 10.1111/bjh.13809. Epub 2015 Nov 13.

4

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.三氧化二砷和全反式维甲酸治疗所有风险组急性早幼粒细胞白血病（AML17）：一项随机、对照、3 期临床试验的结果。

Lancet Oncol. 2015 Oct;16(13):1295-305. doi: 10.1016/S1470-2045(15)00193-X. Epub 2015 Sep 14.

5

Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia.在诱导治疗中加入三氧化二砷可提高新诊断的急性早幼粒细胞白血病患者的生存率。

Eur J Haematol. 2014 Jul;93(1):54-62. doi: 10.1111/ejh.12301. Epub 2014 Apr 1.

6

Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.全反式维甲酸和三氧化二砷治疗急性早幼粒细胞白血病：协同分子靶向治疗的范例

Philos Trans R Soc Lond B Biol Sci. 2007 Jun 29;362(1482):959-71. doi: 10.1098/rstb.2007.2026.

7

Long-term prognosis of childhood acute promyelocytic leukaemia with arsenic trioxide administration in induction and consolidation chemotherapy phases: a single-centre experience.三氧化二砷诱导和巩固化疗阶段治疗儿童急性早幼粒细胞白血病的长期预后：单中心经验。

Eur J Haematol. 2013 Dec;91(6):483-9. doi: 10.1111/ejh.12194. Epub 2013 Sep 17.

8

Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.全反式维甲酸、化疗及三氧化二砷治疗急性早幼粒细胞白血病的长期生存及预后研究：单中心120例患者的经验

Int J Hematol. 1999 Dec;70(4):248-60.

9

Have all-trans retinoic acid and arsenic trioxide replaced all-trans retinoic acid and anthracyclines in APL as standard of care.在急性早幼粒细胞白血病（APL）的治疗中，全反式维甲酸和三氧化二砷是否已取代全反式维甲酸和蒽环类药物成为标准治疗方案。

Best Pract Res Clin Haematol. 2014 Mar;27(1):39-52. doi: 10.1016/j.beha.2014.04.003. Epub 2014 Apr 12.

10

All-Trans Retinoic Acid plus Arsenic Trioxide versus All-Trans Retinoic Acid plus Chemotherapy for Newly Diagnosed Acute Promyelocytic Leukemia: A Meta-Analysis.全反式维甲酸联合三氧化二砷与全反式维甲酸联合化疗治疗新诊断急性早幼粒细胞白血病的Meta分析

PLoS One. 2016 Jul 8;11(7):e0158760. doi: 10.1371/journal.pone.0158760. eCollection 2016.

引用本文的文献

1

Treatment of Central Nervous System Relapse in Acute Promyelocytic Leukemia by Venetoclax: A Case Report.维奈克拉治疗急性早幼粒细胞白血病中枢神经系统复发：一例报告

Front Oncol. 2021 Jul 5;11:693670. doi: 10.3389/fonc.2021.693670. eCollection 2021.

2

Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).三氧化二砷替代或减少急性早幼粒细胞白血病（APL2012 试验）巩固治疗中的化疗。

Proc Natl Acad Sci U S A. 2021 Feb 9;118(6). doi: 10.1073/pnas.2020382118.

3

Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet.